Riboflavin 5-Phosphate Ophthalmic
EPIOXA CROSS-LINKING, Photrexa Cross-linking Kit
NADAC/unit
N/A
No Shortage
Active Shortages
2026-01-20 Discontinuing manufacture of the product as of June 2026., Glaukos Corporation
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.